After a strong start to the year, the value of biotech financings has tailed off a little, but March has seen a clutch of $50 ...

Genentech is halting development of an antibody for two rare genetic diseases after the candidate failed to boost muscle growth, raising questions about whether the molecule can preserve muscle in two ...

To help cover the cost of hosting its nominating convention in April, the Massachusetts Republican Party is offering media outlets a spot on its new “media row" inside Worcester’s DCU Center. It costs ...

WALTHAM, Mass., March 20, 2026 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, inflammatory and immunological, ...

Financing strengthens balance sheet and supports advancement of key development initiatives NEWTON, MA, March 20, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTC: BIXT), a clinical-stage biotechnology ...

The landscape of workplace safety and personal health screenings in the Greater Boston area involves a variety of technical procedures that can often seem complex to the uninitiated. In a major ...

His method of locating genes in human DNA allowed researchers to find disease-causing genes, and later to map the entire, sprawling human genome.

Rhythm Pharmaceuticals is switching up the tempo for its melanocortin-4 receptor (MC4R) agonist Imcivree. | The new FDA nod makes Rhythm Pharma's Imcivree the first approved drug for acquired ...

No. 4 / 2026Zealand Pharma increases its share capital as a result of the exercise of employee warrantsCopenhagen, ...

Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders ...

The Looker selects products independently. If you purchase something from our posts, we may earn a small commission. As ...